Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The second-largest cause of X-linked mental retardation is a deficiency in creatine transporter (CRT; encoded by SLC6A8), which leads to speech and language disorders with severe cognitive impairment. This syndrome, caused by the absence of creatine in the brain, is currently untreatable because CRT is required for creatine entry into brain cells. Here, we developed a brain-specific Slc6a8 knockout mouse (Slc6a8-/y) as an animal model of human CRT deficiency in order to explore potential therapies for this syndrome. The phenotype of the Slc6a8-/y mouse was comparable to that of human patients. We successfully treated the Slc6a8-/y mice with the creatine analog cyclocreatine. Brain cyclocreatine and cyclocreatine phosphate were detected after 9 weeks of cyclocreatine treatment in Slc6a8-/y mice, in contrast to the same mice treated with creatine or placebo. Cyclocreatine-treated Slc6a8-/y mice also exhibited a profound improvement in cognitive abilities, as seen with novel object recognition as well as spatial learning and memory tests. Thus, cyclocreatine appears promising as a potential therapy for CRT deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Desired intake of cyclocreatine was approximately 0.28 mg/g of body weight/day, which is approximately the same as the standard creatine dose used in humans of 285 mg/kg of body weight/day (Kurosawa et al., 2012).”
From TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease (2017) · cites this paper as Kurosawa et al., 2012
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 3×
“Creatine and its phosphorylated form, phosphocreatine, are used as an energy reservoir by buffering ATP concentration via the creatine kinase (CK) reaction (1).”
Inducible Gene Targeting in Mice Using the Cre/loxSystem
Sauer, B. (1998) · Methods · doi:10.1006/meth.1998.0593 · Cited by 762
Park, H. R., Park, M., Choi, J., Park, K.-Y., Chung, H. Y., & Lee, J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.046 · Cited by 374
Dietary ketosis enhances memory in mild cognitive impairment
Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.006 · Cited by 361
Self-citationInborn Metabolic Diseases: Diagnosis and Treatment
(2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8 · Cited by 361
A CamKIIα iCre BAC allows brain‐specific gene inactivation
Casanova, E., Fehsenfeld, S., Mantamadiotis, T., Lemberger, T., Greiner, E., Stewart, A. F., & Schütz, G. (2001) · genesis · doi:10.1002/gene.1078 · Cited by 292
Rae, C., Digney, A. L., McEwan, S. R., & Bates, T. C. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2003.2492 · Cited by 283
Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis
Taicher, G. Z., Tinsley, F. C., Reiderman, A., & Heiman, M. L. (2003) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-2224-3 · Cited by 256
Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study
Braissant, O., Henry, H., Loup, M., Eilers, B., & Bachmann, C. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00269-2 · Cited by 232
Conn, P. M. (2003) · Humana Press eBooks · doi:10.1385/1592593712 · Cited by 224
Research works printed but not linked: 1
- Hoosein, 1995, Anticancer Res., 15, 1339
Cited by
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263
SLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
Rae, C. D. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1199-5 · Cited by 496
Ji, L., Zhao, X., Zhang, B., Kang, L., Song, W., Zhao, B., Xie, W., Chen, L., & Hu, X. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.007 · Cited by 240
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Metadata
- Authors
- Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F.
- Affiliations
- University of Cincinnati (US)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Clark, Joseph F.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-08-01
- Volume
- 122
- Issue
- 8
- Pages
- 2837-2846
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3408730
- OpenAlex
- W2082741813
- Cited by
- 98
- References
- 62
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 11 · 2022: 3 · 2021: 14 · 2020: 8 · 2019: 8 · 2018: 4 · 2017: 6 · 2016: 8 · 2015: 5 · 2014: 10 · 2013: 10 · 2012: 2
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cincinnati Children's Hospital Medical Center
- Tokyo Medical and Dental University
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS049172, NS049172)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- creatine transporter deficiency, SLC6A8, cyclocreatine, X-linked intellectual disability, cognitive impairment, novel object recognition, spatial learning and memory
- MeSH terms
- Animals, Base Sequence, Brain, Cognition, Cognition Disorders, Creatinine, Disease Models, Animal, Female, Humans, Learning, Male, Memory, Mice, Inbred C57BL, Models, Neurological, Phosphocreatine, DNA Primers, Mice, Knockout, Membrane Transport Proteins, Mental Retardation, X-Linked, X-Linked Intellectual Disability, Imidazolidines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. https://app.cochat.ai/papers/10.1172/jci59373
- The paper
- Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F. (2012). Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. Journal of Clinical Investigation. https://doi.org/10.1172/jci59373
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.